Engineering Plasmodium-refractory phenotypes in mosquitoes

Trends in Parasitology

Volumn 19, Issue 9, 2003, Pages 384-387

  Nirmala, Xavier ^a   James, Anthony A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC ENGINEERING; IMMUNE RESPONSE; MOSQUITO; NONHUMAN; PHENOTYPE; PLASMODIUM; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM GALLINACEUM; PROBABILITY; PROTEIN EXPRESSION; REVIEW;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM GALLINACEUM; PROTOZOA;

EID: 0041828360     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4922(03)00188-0     Document Type: Short Survey

References (26)

1. Anon. (1991) Prospects for malaria control by genetic manipulation of its vectors (TDR/BCV/MAL-ENT/91.3), World Health Organization.
2. Braig H.R., Yan G. The spread of genetic constructs in natural insect populations. Letourneau D.K., Burrows B.E. Genetically Engineered Organisms: Assessing Environmental and Human Health Effects. 2001;251-314 CRC Press.
3. Ito J., et al. Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite. Nature. 417:2002;452-455.
4. Holt R.A., et al. The genome sequence of the malaria mosquito Anopheles gambiae. Science. 298:2002;129-149.
5. Atkinson P., James A.A. Germline transformants spreading out to many insect species. Adv. Genet. 47:2002;49-86.
6. Yoshida S., et al. A single-chain antibody fragment specific for the Plasmodium berghei ookinete protein Pbs21 confers transmission blockade in the mosquito midgut. Mol. Biochem. Parasitol. 104:1999;195-204.
7. Capurro M., et al. Virus-expressed, recombinant single-chain antibody blocks sporozoite infection of salivary glands in Plasmodium gallinaceum-infected Aedes aegypti. Am. J. Trop. Med. Hyg. 62:2000;427-433.
8. Stowers A.W., et al. A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies. Infect. Immun. 68:2000;5530-5538.
9. Tsuboi T., et al. Transmission-blocking vaccine of vivax malaria. Parasitol. Int. 52:2003;1-11.
10. Barreau C., et al. Plasmodium gallinaceum: sporozoite invasion of Aedes aegypti salivary glands is inhibited by anti-gland antibodies and by lectins. Exp. Parasitol. 81:1995;332-343.
11. Lal A.A., et al. Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5228-5233.
12. 2 blocks malaria parasite development in the mosquito midgut by inhibiting ookinete association with the midgut surface. J. Exp. Biol. 204:2001;4157-4167.
13. Moreira L.A., et al. Bee venom phospholipase inhibits malaria parasite development in transgenic mosquitoes. J. Biol. Chem. 277:2002;40839-40843.
14. Tsai Y., et al. Disruption of Plasmodium falciparum chitinase markedly impairs parasite invasion of mosquito midgut. Infect. Immun. 69:2001;4048-4054.
15. Dessens J.T., et al. Knockout of the rodent malaria parasite chitinase pbCHT1 reduces infectivity to mosquitoes. Infect. Immun. 69:2001;4041-4047.
16. Langer R.C., et al. Monoclonal antibody against the Plasmodium falciparum chitinase, PfCHT1, recognizes a malaria transmission-blocking epitope in Plasmodium gallinaceum ookinetes unrelated to the chitinase PgCHT1. Infect. Immun. 70:2002;1581-1590.
17. Langer R.C., et al. Identification of novel Plasmodium gallinaceum zygote- and ookinete-expressed proteins as targets for blocking malaria transmission. Infect. Immun. 70:2002;102-106.
18. Gwadz R.W., et al. Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes. Infect. Immun. 57:1989;2628-2633.
19. Shahabuddin M., et al. Plasmodium gallinaceum: differential killing of some mosquito stages of the parasite by insect defensin. Exp. Parasitol. 89:1998;103-112.
20. Blandin S., et al. Reverse genetics in the mosquito Anopheles gambiae: targeted disruption of the defensin gene. EMBO Rep. 3:2002;852-856.
21. Rodriguez M.C., et al. Effect of a cecropin-like synthetic peptide (Shiva-3) on the sporogonic development of Plasmodium berghei. Exp. Parasitol. 80:1995;596-604.
22. Yoshida S., et al. Bacteria expressing single-chain immunotoxin inhibit malaria parasite development in mosquitoes. Mol. Biochem. Parasitol. 113:2001;89-96.
23. Boete C., et al. Reduced efficacy of the immune melanization response in mosquitoes infected by malaria parasites. Parasitology. 125:2002;93-98.
24. Dimopoulos G. Insect immunity and its implication in mosquito-malaria interactions. Cell Microbiol. 5:2003;3-14.
25. Luckhart S., et al. The mosquito Anopheles stephensi limits malaria parasite development with inducible synthesis of nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 95:1998;5700-5705.
26. Conde R., et al. Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett. 471:2000;165-166.